Results 131 to 140 of about 858,069 (214)

Fibroblast circSamd4 promotes cardiac fibrosis via activating plasminogen activator inhibitor-1. [PDF]

Redox Biol
Chen Y, Zhang Z, Cheng Y, Chen X, Zhou J, Wei Z, Yao H, Zhang S, Kong Q, Tang H, Wu W, Zhou Z, Tang X, Liu X.   +13 more
europepmc   +1 more source

Retroperitoneal Fibrosis

Journal of Osteopathic Medicine, 2017
Jennifer, Conard, Michelino, Mancini
openaire   +2 more sources

Harnessing artificial intelligence for the assessment of liver fibrosis and steatosis <i>via</i> multiparametric ultrasound. [PDF]

World J Gastroenterol
Viceconti N, Andaloro S, Paratore M, Miliani S, D'Acunzo G, Cerniglia G, Mancuso F, Melita E, Gasbarrini A, Riccardi L, Garcovich M.   +10 more
europepmc   +1 more source

Engineered T cell therapy for the treatment of cardiac fibrosis during chronic phase of myocarditis. [PDF]

Theranostics
Hua X, Sun Z, Liang Z, Huang Y, Mo H, Dong F, Mo S, Yang X, Zhang N, Chen X, Liao S, Qi Z, Zhang R, Guan S, Li L, Xu Y, Song J.   +16 more
europepmc   +1 more source

Response to letter regarding "beyond inflammation: what drives the self-perpetuating cycle of fibrosis in IBD?" [PDF]

Ann Med
Xiao S.
europepmc   +1 more source

A Proteomics Resource Investigating Fibrosis: Proof-of-Concept for Identifying Novel Drug Candidates. [PDF]

Proteomics
Devos H, Makridakis M, Stroggilos R, Campos MAJ, Tserga A, Mokou M, Roubelakis MG, Zoidakis J, Vlahou A, Latosinska A.   +9 more
europepmc   +1 more source

SAT-682 Innovative Artificial Intelligence (AI) SXR platform use to aid diagnosis of metabolic dysfunction associated steatohepatitis (MASH) and liver fibrosis [PDF]

Veronica Preda, Michael K. Wilson, Terry Carney, Martina Preda   +3 more
openalex   +1 more source

Prevalence of MASLD and fibrosis assessed by transient elastography in U.S. adolescents: insights from NHANES 2017-2023. [PDF]

Diabetol Metab Syndr
Wu J, Huang J, Cao S, Lyu Y, Yu P, Feng T, Chen B, Xie F, Zhang G, Zhuang K, Li A, To KF, Kang W.   +12 more
europepmc   +1 more source